Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tomaculous neuropathy 1 Stomach Neoplasms 1 Renal Insufficiency, Chronic 1 Renal Artery Obstruction 1 Pulmonary Embolism 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Neuroma 1 Median Neuropathy 1 Lung Neoplasms 1 Insulin Resistance 1 Inflammation 1 Head and Neck Neoplasms 1 Hand Injuries 1 Disease 1 Carpal Tunnel Syndrome 1

Interventions

Bismuth 6 Esomeprazole 5 Amoxicillin 5 Tetracycline 4 Oxaliplatin 4 apatinib 3 Irinotecan 3 Furazolidone 3 Fluorouracil 3 Clarithromycin 3 fish oil triglycerides 2 Rabeprazole 2 Leucovorin 2 Indocyanine Green 2 Berberine 2 sintilimab 1 potassium oxonate 1 lenvatinib 1 iron isomaltoside 1000 1 ilaprazole 1 gimeracil 1 ferric carboxymaltose 1 doxifluridine 1 alanylglutamine 1 Water 1 Trastuzumab 1 Tranexamic Acid 1 Tobacco Use Cessation Devices 1 Thalidomide 1 Tegafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Stomach Neoplasms × Acetylcysteine × Clear all

NCT01653171 2018-04-10

PRUE

Pontificia Universidad Catolica de Chile

Phase 4 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡